The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT

Chetan Bettegowda1, Xin Huang, Jimmy Lin

  • 1The Howard Hughes Medical Institute, The Ludwig Center for Cancer Genetics & Therapeutics, The Sidney Kimmel Comprehensive Cancer Center, Department of Pharmacology and Molecular Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.

Nature Biotechnology
|November 23, 2006
PubMed

Insights

This study sequenced the Clostridium novyi-NT genome, revealing novel genes and transposition. Researchers discovered that C. novyi-NT spores contain unique mRNA, distinct from vegetative forms, advancing cancer therapy research.

Area of Science:

  • Microbiology
  • Genomics
  • Cancer Therapy

Background:

  • Bacteriolytic anti-cancer therapies utilize attenuated bacterial strains for tumor targeting.
  • Clostridium novyi-NT spores show significant anti-tumor effects in preclinical models.

Purpose of the Study:

  • To determine the complete genomic sequence of Clostridium novyi-NT.
  • To identify novel genes and genetic elements within C. novyi-NT.
  • To analyze gene expression during different life cycle stages and in tumor infections.

Main Methods:

  • Whole-genome sequencing of Clostridium novyi-NT.
  • Bioinformatic analysis to identify genes and novel transposition events.
  • Transcriptome analysis (RNA sequencing) of C. novyi-NT in vitro and in vivo.

Main Results:

  • The 2.55-Mb genome of C. novyi-NT was sequenced, revealing a novel transposition type and 139 unique genes.
  • Transcriptome analysis identified distinct mRNA populations in spores versus vegetative C. novyi-NT cells.
  • Gene expression patterns were characterized across various life cycle stages and during tumor colonization.

Conclusions:

  • The genomic and transcriptomic data provide a foundation for understanding C. novyi-NT biology.
  • The discovery of spore-specific transcripts has implications for developing targeted bacterial cancer therapies.
  • Further research into C. novyi-NT's unique genetic makeup can optimize its therapeutic potential.

Related Concept Videos

Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this defense.
Genomic DNA in Eukaryotes00:58

Genomic DNA in Eukaryotes

Eukaryotes have large genomes compared to prokaryotes. To fit their genomes into a cell, eukaryotic DNA is packaged extraordinarily tightly inside the nucleus. To achieve this, DNA is tightly wound around proteins called histones, which are packaged into nucleosomes that are joined by linker DNA and coil into chromatin fibers. Additional fibrous proteins further compact the chromatin, which is recognizable as chromosomes during certain phases of cell division.
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...